AzTrials
AzTrials

Peritoneal DialysisCAPER-PDNCT07634211

Combined Aerobic and Resistance Exercise in Peritoneal Dialysis Patients

A study testing Combined Aerobic and Resistance Exercise in people with Peritoneal Dialysis, run by Dilek GİBYELİ GENEK at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this randomized controlled trial was to learn whether a combined aerobic and resistance exercise program could improve physical function and muscle health in people receiving peritoneal dialysis. Researchers compared an exercise group with a control group to evaluate the effects of regular exercise. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Peritoneal Dialysis
What is being tested?
Combined Aerobic and Resistance Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jul 2022to 30 Sep 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 18 years or older
  • Receiving peritoneal dialysis for at least 6 months
  • Ability to sit and stand independently

Who cannot join

  • Myocardial infarction within the previous 6 months
  • History of cardiac surgery
  • Uncontrolled hypertension
  • Pericardial or pleural effusion
  • Aortic stenosis
  • Active lower extremity amputation, prosthesis, or fracture
Show all 9Show fewer
  • History of osteoporotic fractures
  • Regular participation in sports or structured exercise
  • Advanced cognitive impairment

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Mugla Sitki Kocman University Faculty of Medicine, Mugla Training and Research Hospital

    Muğla, Muğla, 48000

Other trials in Turkey (Türkiye)

About this study

Official title: Combined Aerobic and Resistance Exercise in Peritoneal Dialysis Patients: A Randomized Controlled Trial

The goal of this randomized controlled trial was to learn whether a combined aerobic and resistance exercise program could improve physical function and muscle health in people receiving peritoneal dialysis. Researchers compared an exercise group with a control group to evaluate the effects of regular exercise.

The main questions the study aimed to answer were:

Read more
  • Can regular exercise improve physical performance and muscle strength in people receiving peritoneal dialysis?
  • Can regular exercise improve body composition and blood markers related to muscle health?

Before the exercise program, participants completed a one-month training period to learn the exercises and practice them safely.

Participants in the exercise group:

  • Performed combined aerobic and resistance exercises for 8 weeks
  • Completed assessments before and after the exercise program

Participants in the control group:

  • Continued their usual care
  • Completed assessments before and after the study period
Read the detailed description

People receiving peritoneal dialysis often experience reduced physical function, muscle weakness, and changes in body composition. This randomized controlled trial evaluated the effects of a combined aerobic and resistance exercise program in adults receiving peritoneal dialysis.

Before the intervention, participants completed a one-month training and adaptation period to learn the exercises and ensure safe participation. Participants were then assigned to either an exercise group or a control group. The exercise group performed a structured combined aerobic and resistance exercise program for 8 weeks, while the control group continued usual care.

Researchers evaluated physical performance, muscle strength, body composition, and blood markers related to muscle health before and after the intervention period. The study aimed to determine whether regular exercise could improve physical function and muscle health in people receiving peritoneal dialysis.

Being tested
Combined Aerobic and Resistance Exercise
Keywords
Peritoneal Dialysis, exercise, Physical Performance, Muscle Strength, Body Composition
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Combined Aerobic and Resistance ExerciseBehavioural

    Participants performed a structured combined aerobic and resistance exercise program for 8 weeks. Before the intervention period, participants completed a one-month training and adaptation phase to learn the exercises and ensure safe participation. The exercise program aimed to improve physical performance, muscle strength, and muscle health in people receiving peritoneal dialysis.

Study groups in NCT07634211
Study groupRoleWhat they receive
exercise groupExperimentalParticipants performed a combined aerobic and resistance exercise program for 8 weeks.
Receives: Behavioral: Combined Aerobic and Resistance Exercise
control groupNo interventionParticipants continued their usual care during the study period without a structured exercise program.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Physical Performance

    Changes in physical performance assessed using the 6-minute walk test after 8 weeks of combined aerobic and resistance exercise.

    Measured: Baseline and after 8 weeks of intervention

  2. Changes in right handgrip strength

    Changes in right handgrip strength measured in kilograms after 8 weeks of combined aerobic and resistance exercise.

    Measured: Baseline and after 8 weeks of intervention

  3. Changes in left handgrip strength

    Changes in left handgrip strength measured in kilograms after 8 weeks of combined aerobic and resistance exercise.

    Measured: Baseline and after 8 weeks of intervention

  4. Changes in leg strength

    Changes in lower extremity muscle strength measured using a leg and back dynamometer after 8 weeks of combined aerobic and resistance exercise.

    Measured: Baseline and after 8 weeks of intervention

Secondary outcomes (7)
  1. Changes in flexibility

    Changes in flexibility assessed using the Modified Back-Saver Sit-and-Reach Test after 8 weeks of combined aerobic and resistance exercise.

    Measured: Baseline and after 8 weeks of intervention

  2. Changes in Fat Tissue Index (FTI)

    Changes in Fat Tissue Index measured by by bioimpedance spectroscopy after 8 weeks of combined aerobic and resistance exercise.

    Measured: Baseline and after 8 weeks of intervention

  3. Changes in Lean Tissue Index (LTI)

    Changes in Lean Tissue Index measured by by bioimpedance spectroscopy after 8 weeks of combined aerobic and resistance exercise.

    Measured: Baseline and after 8 weeks of intervention

  4. Changes in serum IGF-1 levels

    Changes in serum insulin-like growth factor-1 (IGF-1) levels after 8 weeks of combined aerobic and resistance exercise.

    Measured: Baseline and after 8 weeks of intervention

  5. Changes in serum ACTH levels

    Changes in serum adrenocorticotropic hormone (ACTH) levels after 8 weeks of combined aerobic and resistance exercise.

    Measured: Baseline and after 8 weeks of intervention

  6. Changes in serum myostatin levels

    Changes in serum myostatin levels after 8 weeks of combined aerobic and resistance exercise.

    Measured: Baseline and after 8 weeks of intervention

  7. Changes in serum irisin levels

    Changes in serum irisin levels after 8 weeks of combined aerobic and resistance exercise.

    Measured: Baseline and after 8 weeks of intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jun 2026
  2. Study start1 Jul 2022
  3. Primary completion30 Sep 2022
  4. Study completion30 Sep 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants were assigned to either an exercise group or a control group and followed in parallel throughout the study period
Masking
None (open label)
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07634211
Sponsor's protocol ID
PD-EX-2022
Other IDs
Ethics Approval 9/XVI-2022
Acronym
CAPER-PD
Status last verified
Jun 2026
First submitted
11 May 2026
Last updated
8 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared to protect participant privacy and confidentiality.

Publications

  • Lu Y, Wang Y, Lu Q. Effects of Exercise on Muscle Fitness in Dialysis Patients: A Systematic Review and Meta-Analysis. Am J Nephrol. 2019;50(4):291-302. doi: 10.1159/000502635. Epub 2019 Sep 3.

    PubMed 31480056
  • Heiwe S, Jacobson SH. Exercise training for adults with chronic kidney disease. Cochrane Database Syst Rev. 2011 Oct 5;2011(10):CD003236. doi: 10.1002/14651858.CD003236.pub2.

    PubMed 21975737
  • Uchiyama K, Washida N, Morimoto K, Muraoka K, Kasai T, Yamaki K, Miyashita K, Wakino S, Itoh H. Home-based Aerobic Exercise and Resistance Training in Peritoneal Dialysis Patients: A Randomized Controlled Trial. Sci Rep. 2019 Feb 22;9(1):2632. doi: 10.1038/s41598-019-39074-9.

    PubMed 30796338

Questions about this trial

What is this clinical trial studying?

A study testing Combined Aerobic and Resistance Exercise in people with Peritoneal Dialysis, run by Dilek GİBYELİ GENEK at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Physical Performance (time frame: Baseline and after 8 weeks of intervention). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07634211, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in